65+ Publicly Traded Digital Health Companies

Over the last decade, we have witnessed extraordinary growth in digital health, with technology increasingly becoming the cornerstone of modern healthcare services. We’ve seen many startups in our space mature, some of which are now household names like Hims, GoodRx, Noom, and TalkSpace.

As these venture-backed companies mature, many seek an exit. This leaves them with two choices: get acquired or go public. A significant number opt for the public market, either through an Initial Public Offering (IPO) or a Special Purpose Acquisition Company (SPAC) route. But they all have the same goal: to unlock access to capital, provide liquidity to early investors, enhance their visibility, or facilitate future acquisitions.

As a founder, investor, and general digital health enthusiast, I’ve been tracking these companies for some time. Below I’ll briefly share a little background on digital health IPOs by year, and a list of all the currently active companies valued over $100 million (and what they do). Let’s dive in.

Digital health IPOs by year

There are currently over 65  publicly traded digital health companies, valued from $25 million to over $46 billion, with a median value of $753 million. Today, 31 of them are valued over $1 billion (to compare, there are 86 privately held digital health companies “valued” at over $1B).

A good portion (21/57) of the active public digital health companies IPO’d in 2021, a year with unprecedented activity in the space. In fact, there were more digital health IPOs in 2021 than the previous decade combined. This rise was, in part, spurred by the increasing popularity of SPACs. These 'blank check' companies became an attractive route for digital health firms looking to expedite their journey to the public market. Notably, out of the 37 digital health IPOs in 2021, half took the SPAC path.

A list of publicly traded digital health companies

So, which ones are still around? Below are publicly listed health tech companies with a market cap of at least $100 million as of November 2025. They are listed in order of market cap, from highest to lowest. For a complete list, including current market cap, years to IPO, as well as delisted companies, download this database of digital health companies.

Company Ticker Year of IPO Description
IQVIAIQV2013Life sciences data and CRO services
Veeva SystemsVEEV2013Life sciences cloud software
DexComDXCM2005Continuous glucose monitoring
ResmedRMD1995Sleep and respiratory care devices
Guardant HealthGH2018Cancer diagnostics and liquid biopsy
TempusTEM2024AI-powered precision medicine
HealthEquityHQY2014Health savings accounts
Oscar HealthOSCR2021Technology-enabled health insurer
Hims & HersHIMS2021Direct-to-consumer telehealth
Caris Life SciencesCAI2025Precision oncology diagnostics
Hinge HealthHNGE2025Digital musculoskeletal care
BillionToOneBLLN2025Molecular diagnostics
WaystarWAY2024Revenue cycle management
DoximityDOCS2021Physician network and workflow tools
iRhythm TechnologiesIRTC2016Cardiac monitoring
LifeStance HealthLFST2021Outpatient behavioral health
Alignment HealthcareALHC2021Medicare Advantage insurer
Peloton InteractivePTON2019Connected fitness
Privia HealthPRVA2021Physician enablement and value-based care
HeartFlowHTFL2025AI-powered cardiac imaging
ProgynyPGNY2019Fertility benefits platform
Clover HealthCLOV2020Medicare Advantage insurer
OmnicellOMCL2001Pharmacy automation
Astrana HealthASTH2009Value-based care platform
GeneDxWGS2021Genomic diagnostics
agilon healthAGL2021Value-based care enablement
Teladoc HealthTDOC2015Virtual care platform
Butterfly NetworkBFLY2021Handheld ultrasound
SchrödingerSDGR2020Computational drug discovery
Kestra MedicalKMTS2025Cardiac monitoring devices
Omada HealthOMDA2025Virtual chronic care
GoodRxGDRX2020Prescription savings marketplace
CertaraCERT2020Drug development software
HealthStreamHSTM2011Healthcare workforce training
CeriBellCBLL2025Rapid EEG diagnostics
PhreesiaPHR2019Patient intake and engagement
Beta BionicsBBNX2025Automated insulin delivery
NeuroPaceNPCE2021Epilepsy neurostimulation
ClaritevCTEV2020Healthcare cost management
Weave CommunicationsWEAV2021Patient communications software
Evolent HealthEVH2015Specialty care management
NRC HealthNRC1997Patient experience analytics
TruBridgeTBRG2002Rural healthcare IT
SOPHiA GENETICSSOPH2021Genomic analytics platform
Simulations PlusSLP1997Drug simulation software
SpokSPOK1992Clinical communications
LifeMDLFMD2001Direct-to-consumer telehealth
OwletOWLT2021Infant monitoring devices
AmwellAMWL2020Virtual care infrastructure
Definitive HealthcareDH2021Healthcare commercial intelligence
CareCloudCCLD2014Practice management software
Health CatalystHCAT2019Healthcare analytics
OptimizeRxOPRX2018Life sciences engagement platform
Outset MedicalOM2020Dialysis technology
Beachbody CompanyBODI2021Digital fitness platform
Health In TechHIT2024Benefits administration technology
DocGoDCGO2021Mobile healthcare services
DarioHealthDRIO2013Digital chronic care
eHealthEHTH2006Online insurance marketplace
HeartBeamBEAT2021Portable cardiac diagnostics
OneMedNetONMD2023Medical imaging data platform
MovanoMOVE2021Health wearables
GoHealthGOCO2020Medicare insurance marketplace
Wellgistics HealthWGRX2025Pharmacy supply chain technology
VSee HealthVSEE2024Telehealth software
Vicarious SurgicalRBOT2021Surgical robotics
Healthcare TriangleHCTI2021Healthcare cloud services
Halle Tecco

Halle Tecco has dedicated her career to making healthcare massively better. She is the founder of Rock Health and has backed and advised dozens of healthcare companies. She teaches future healthcare leaders at Columbia Business School and Harvard Medical School, and serves on the boards of Collective Health and Cofertility. Tecco’s work has been featured in The New York Times, The Wall Street Journal, and Bloomberg. She was named as one of Goldman Sach’s Most Intriguing Entrepreneurs and listed on Fast Company's Most Creative People in Business 2023. She has spoken at the Aspen Ideas Festival, CES, TechCrunch Disrupt, and was a SXSW Keynote speaker. Tecco holds an MBA from Harvard Business School and an MPH from Johns Hopkins University.

Previous
Previous

I Asked 12 Healthcare Investors from Intern to Partner: How Did You Break Into VC?

Next
Next

Read This Before You Accept Stock Options